Unveiling the Neural Mechanisms of 5-HT7 in Sleep Apnea Induced by Arousal Dysregulation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-30

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obstructive sleep apnea (OSA), recognized as a highly prevalent sleep breathing disorder with severe complications, features a complex etiology. Poor understanding of disease pathogenesis limits the overall efficacy of interventions. Studies have found that upregulation of 5-HT7 expression in the lateral hypothalamus (LH) could reduce arousal threshold (ArTH) and induce an inhibitory effect to the respiratory central, which was associated with hypoxic stimulation. Therefore, the investigators speculate that the structural/functional abnormalities of the arousal-respiratory neural circuit, mediated by LH5-HT7, may play an important role in the pathogenesis of OSA. To verify the hypothesis, the investigators will compare the ArTH and the brain network presenting by multimodal MRI in normal individuals, snoring individuals, and OSA patients, to reveal the correlation between arousal dysregulation and the structure/function of LH regions; compare the changes of ArTH and brain network in OSA patients with low ArTH before and after CPAP treatment, to verify the interaction between hypoxia and arousal dysregulation, as well as whether the damaging performance of the arousal-respiratory brain regulation area in OSA patients can be partially reversed by relieving hypoxia. Above all, the joint application B team will further analyze the LH5-HT7 neural mechanism in the pathogenesis of OSA.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study on the Material Basis of Syndromes of Insomnia and the Correlation Between Infrared Image

NCT04141280

Insomnia

UNKNOWN

The Sleepless Brain: Neuroimaging Support for a Differential Diagnosis of Insomnia

NCT02821234

Insomnia

COMPLETED NA

Quantitation of Glymphatic Functioning in Sleep and Meditative States

NCT04506892

Parkinson Disease Sleep

COMPLETED NA

Investigating Neuronal and Peripheral Markers of Brain Heart Interaction in Healthy Participants Under Stress

NCT05358314

Heart Rate Magnetic Resonance Imaging Stress, Physiological

COMPLETED

Study on Cognitive Impairment of Insomnia Based on MRI

NCT05659511

Insomnia Cognitive Disorder MRI

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study consists of two parts: The first part is a cross-sectional study comparing the differences in arousal threshold, loop gain, and the brain network structure and functional connectivity of the brain areas involved in micro-arousal-respiratory center regulation between the non-OSA group (including healthy individuals and those with simple snoring) and the OSA group; The second part is a cohort study, which conducts a three-month longitudinal follow-up of the OSA group to observe the changes in the indicators of the structure and function of the core brain areas related to ArTH and micro-arousal-respiratory center regulation after the correction of intermittent hypoxia through CPAP treatment.The specific research content is as follows:

1. ArTH Comparative Analysis Based on Multimodal Assessment of OSA Etiology Select untreated OSA patients, simple snorers (with snoring symptoms, AHI \< 5 events/h), and healthy individuals (without snoring symptoms, AHI \< 5 events/h), matched for age and gender, and divide them into two groups.Non-OSA group (including healthy individuals and those with simple snoring) and OSA group . After all study participants have undergone upper airway CT, they are all subjected to overnight PSG with synchronous esophageal pressure monitoring, end-tidal carbon dioxide monitoring, and genioglossus electromyography (GGEMG) monitoring. A pharyngeal pressure regulation device is used to induce respiratory events with micro-arousals in the study participants under resistive ventilation, and the trends of ArTH, GGEMG, and respiratory drive (loop gain, LG) are analyzed among different sleep stages. Then, by integrating the above multimodal etiological parameters, the differences in micro-arousal regulation between OSA patients (high airway resistance and hypoxia group), simple snorers (high airway resistance without hypoxia group), and healthy individuals (low airway resistance without hypoxia group) are clarified. Furthermore, the weight of ArTH in the etiology of OSA is calculated, and the individual differences in ArTH among OSA patients and its correlation with the severity of the disease are analyzed.
2. Feature Analysis of OSA Micro-arousal-Respiratory Central Regulation Network Based on Multimodal MRI By integrating multimodal MRI imaging data, including structural T1, diffusion tensor imaging (DTI), and resting-state functional magnetic resonance imaging (rs-fMRI), the differences in brain network structure and functional connectivity of brain regions involved in micro-arousal-respiratory central regulation between OSA patients, simple snorers, and healthy individuals with different ArTH levels are compared. This reveals the patterns of functional connectivity changes and structural basis related to micro-arousal abnormal regulation in OSA patients, and clarifies the correlation with the lateral hypothalamus (LH) brain region.
3. Comparative Analysis of LH-Related Brain Region Structure and ArTH in OSA Patients with Low ArTH Before and After CPAP Treatment After OSA patients with different ArTH levels have undergone more than 6 months of CPAP treatment, ArTH and multimodal MRI imaging data (T1, DTI, rs-fMRI) are re-measured to observe the changes in ArTH and the structure/function of the core brain regions regulating micro-arousal-respiratory central in OSA patients after correcting intermittent hypoxia with CPAP treatment. These changes are compared with the ArTH and brain network structure of healthy controls to verify the damaging effects of hypoxia on brain networks and to clarify whether the damaging manifestations of the micro-arousal-respiratory central regulation regions in OSA patients can be partially reversed with treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-OSA patients group

Healthy individuals (without snoring symptoms, AHI \< 5 events/h)；Simple snorers (with snoring symptoms, AHI \< 5 events/h)

MRI

Intervention Type DIAGNOSTIC_TEST

Multimodal MRI technology is a method that combines various magnetic resonance imaging techniques, providing more comprehensive images and information about human tissues and organs. These different imaging techniques include, but are not limited to:

Structural MRI (sMRI): Provides information about the types of brain tissues, such as gray matter, white matter, and cerebrospinal fluid.

Functional MRI (fMRI): Dynamically measures the hemodynamic response related to brain neural activity, commonly used to study brain functional activities.

Diffusion Tensor Imaging (DTI): Offers information on the structural connections between brain regions, which can be used to study the neural fiber pathways of the brain

OSA patients

Patients diagnosed with OSA

MRI

Intervention Type DIAGNOSTIC_TEST

Multimodal MRI technology is a method that combines various magnetic resonance imaging techniques, providing more comprehensive images and information about human tissues and organs. These different imaging techniques include, but are not limited to:

Structural MRI (sMRI): Provides information about the types of brain tissues, such as gray matter, white matter, and cerebrospinal fluid.

Functional MRI (fMRI): Dynamically measures the hemodynamic response related to brain neural activity, commonly used to study brain functional activities.

Diffusion Tensor Imaging (DTI): Offers information on the structural connections between brain regions, which can be used to study the neural fiber pathways of the brain

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI

Multimodal MRI technology is a method that combines various magnetic resonance imaging techniques, providing more comprehensive images and information about human tissues and organs. These different imaging techniques include, but are not limited to:

Structural MRI (sMRI): Provides information about the types of brain tissues, such as gray matter, white matter, and cerebrospinal fluid.

Functional MRI (fMRI): Dynamically measures the hemodynamic response related to brain neural activity, commonly used to study brain functional activities.

Diffusion Tensor Imaging (DTI): Offers information on the structural connections between brain regions, which can be used to study the neural fiber pathways of the brain

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PSG Genioglossus Electromyography

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

OSA Patients:

* Age between 20 and 60 years.
* Symptoms of sleep snoring and daytime sleepiness.
* Confirmed diagnosis of OSA following overnight sleep monitoring.

Simple Snorers:

* Age between 20 and 60 years.
* Symptoms of sleep snoring.
* Overnight sleep monitoring indicates not meeting the OSA diagnosis.

Healthy Controls:

* Age between 20 and 60 years.
* No symptoms of sleep snoring.
* Overnight sleep monitoring rules out the diagnosis of OSA.

Exclusion Criteria

* Presence of severe pulmonary, neurological, or cardiovascular complications.
* History of long-term non-invasive positive pressure ventilation treatment (more than 3 months) or upper airway surgery.
* Sleep-disordered breathing due to special etiologies such as hypothyroidism, acromegaly, vocal cord paralysis, etc.
* Presence of severe mental illness, long-term alcohol abuse, or a history of prolonged use of sedative-hypnotic drugs.
* Central sleep apnea predominant sleep disorders due to various causes.
* Severe craniofacial deformities, myasthenia gravis, or other known myopathic histories.
* Patients with peripheral neuropathy caused by diabetes, autoimmune diseases, etc.
* Patients with comorbid insomnia, anxiety, depression, or other types of sleep disorders.

Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes